+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis



Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis



Liver 14(1): 32-36



Liver function tests and liver morphology were studied in 18 patients with cystic fibrosis (CF) for a period of 3 years. The patients were 5-19 years of age at the start of the study. Nine patients received regular supplementation of essential fatty acids (Intralipid) and nine sex- and age-matched patients, with as similar clinical status as possible but without fat emulsion treatment, were followed as controls. There were no significant differences between the two groups with regard to the parameters of liver function, including determinations of bile acids in serum and urine. Histological examinations of liver biopsies suggested less progression of liver disease in the fatty acid supplemented group, including fatty infiltration of the hepatocytes, evaluated morphometrically. The results show that regular supplementation of fat emulsions has no negative effects in the liver of patients with CF, and the lessening of progression of liver damage suggests that essential fatty acid deficiency might contribute to the liver damage in this disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008962990

Download citation: RISBibTeXText

PMID: 8177027

DOI: 10.1111/j.1600-0676.1994.tb00004.x


Related references

Effect of long-term oral beta-carotene supplementation on indices of liver function in cystic fibrosis. Gastroenterology 108(4 Suppl. ): A1199, 1995

Effect on renal function of essential fatty acid supplementation in cystic fibrosis. Journal of Pediatrics 115(2): 242-250, 1989

The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukotrienes and Essential Fatty Acids 108: 45-50, 2016

Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases. Journal of Nutritional Biochemistry 26(1): 36-43, 2015

Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function. Annals of Nutrition and Metabolism 44(1): 30-37, 2000

Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease. Journal of Pediatrics 177: 59-65.E1, 2016

Fatty acid supplementation in cystic fibrosis. Monographs in Paediatrics 10: 1-4, 1979

Is there a case for n-3 fatty acid supplementation in cystic fibrosis?. Current Opinion in Clinical Nutrition and Metabolic Care 8(2): 153-159, 2005

Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis. American Journal of Transplantation 12(4): 954-964, 2012

Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukotrienes and Essential Fatty Acids 77(5-6): 309-318, 2007

Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. Journal of Clinical Gastroenterology 32(4): 324-328, 2001

Clinical outcome of long-term treatment of ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Paumgartner, G, Stiehl, A, Gerok, W Falk Symposium; Bile acids in hepatobiliary diseases: Basic research and clinical application 318-322, 1997

A therapeutic trial of fatty acid supplementation in cystic fibrosis. Pediatrics 57(4): 474-479, 1976

Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis. Journal of Pediatrics 141(2): 157-159, 2002

Long chain fatty acid metabolism and essential fatty acid deficiency with special emphasis on cystic fibrosis. Bracco, U. And R. J. Deckelbaum (ed.). Nestle Nutrition Workshop Series, Vol. 28. Polyunsaturated Fatty Acids In Human Nutrition; Meeting, Mexico City, Mexico, November 27-30,. Xi 243p. Nestec Ltd: Vevey, Switzerland; Raven Press: New York, New York, Usa. Illus. 159-167, 1992